175 related articles for article (PubMed ID: 29735551)
41. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.
Nadeu F; Royo R; Massoni-Badosa R; Playa-Albinyana H; Garcia-Torre B; Duran-Ferrer M; Dawson KJ; Kulis M; Diaz-Navarro A; Villamor N; Melero JL; Chapaprieta V; Dueso-Barroso A; Delgado J; Moia R; Ruiz-Gil S; Marchese D; Giró A; Verdaguer-Dot N; Romo M; Clot G; Rozman M; Frigola G; Rivas-Delgado A; Baumann T; Alcoceba M; González M; Climent F; Abrisqueta P; Castellví J; Bosch F; Aymerich M; Enjuanes A; Ruiz-Gaspà S; López-Guillermo A; Jares P; Beà S; Capella-Gutierrez S; Gelpí JL; López-Bigas N; Torrents D; Campbell PJ; Gut I; Rossi D; Gaidano G; Puente XS; Garcia-Roves PM; Colomer D; Heyn H; Maura F; Martín-Subero JI; Campo E
Nat Med; 2022 Aug; 28(8):1662-1671. PubMed ID: 35953718
[TBL] [Abstract][Full Text] [Related]
42. Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade.
Herman SE; Wiestner A
Semin Oncol; 2016 Apr; 43(2):222-32. PubMed ID: 27040700
[TBL] [Abstract][Full Text] [Related]
43. Richter syndrome: an aggressive transformation.
Streu E
Oncol Nurs Forum; 2015 Mar; 42(2):200-3. PubMed ID: 25806888
[TBL] [Abstract][Full Text] [Related]
44. Spontaneous tumor lysis syndrome in a patient with diffuse large B cell lymphoma and Richter syndrome.
Tufan A; Unal N; Koca E; Onal I; Aksu S; Haznedaroglu I
Ann Hematol; 2006 Mar; 85(3):183-4. PubMed ID: 16311735
[No Abstract] [Full Text] [Related]
45. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
Wang H; Lu J; Tang J; Chen S; He K; Jiang X; Jiang W; Teng L
BMC Cancer; 2017 Mar; 17(1):191. PubMed ID: 28292264
[TBL] [Abstract][Full Text] [Related]
46. Predictive markers and driving factors behind Richter syndrome development.
Fangazio M; De Paoli L; Rossi D; Gaidano G
Expert Rev Anticancer Ther; 2011 Mar; 11(3):433-42. PubMed ID: 21417856
[TBL] [Abstract][Full Text] [Related]
47. Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
Tadmor T; Bejar J; Attias D; Polliack A
Br J Haematol; 2011 Oct; 155(2):135. PubMed ID: 21973072
[No Abstract] [Full Text] [Related]
48. ZNF683 marks a CD8
Parry EM; Lemvigh CK; Deng S; Dangle N; Ruthen N; Knisbacher BA; Broséus J; Hergalant S; Guièze R; Li S; Zhang W; Johnson C; Long JM; Yin S; Werner L; Anandappa A; Purroy N; Gohil S; Oliveira G; Bachireddy P; Shukla SA; Huang T; Khoury JD; Thakral B; Dickinson M; Tam C; Livak KJ; Getz G; Neuberg D; Feugier P; Kharchenko P; Wierda W; Olsen LR; Jain N; Wu CJ
Cancer Cell; 2023 Oct; 41(10):1803-1816.e8. PubMed ID: 37738974
[TBL] [Abstract][Full Text] [Related]
49. Richter Syndrome: From Molecular Pathogenesis to Druggable Targets.
Mouhssine S; Gaidano G
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230566
[TBL] [Abstract][Full Text] [Related]
50. Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
Khan M; Siddiqi R; Thompson PA
Ann Hematol; 2018 Jan; 97(1):1-15. PubMed ID: 29063177
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales.
Federmann B; Mueller MR; Steinhilber J; Horger MS; Fend F
Ann Hematol; 2018 Oct; 97(10):1859-1868. PubMed ID: 29947976
[TBL] [Abstract][Full Text] [Related]
52. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
Maddocks K; Jones JA
Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
[TBL] [Abstract][Full Text] [Related]
53. Transformation in Low-grade B-cell Neoplasms.
Montgomery ND; Mathews SP
Surg Pathol Clin; 2016 Mar; 9(1):79-92. PubMed ID: 26940269
[TBL] [Abstract][Full Text] [Related]
54. Highly Tumorigenic Diffuse Large B Cell Lymphoma Cells Are Produced by Coculture with Stromal Cells.
Lin Z; Chen B; Wu T; Xu X
Acta Haematol; 2018; 139(4):201-216. PubMed ID: 29791894
[TBL] [Abstract][Full Text] [Related]
55. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
Mato A; Jauhari S; Schuster SJ
Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792
[TBL] [Abstract][Full Text] [Related]
56. Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.
Bernasconi P; Paulli M; Orlandi E; Perfetti V; Giardini I; Zibellini S; Vanelli L; Tenore AM; Algarotti A; Boni M; De Amici M; Brusamolino E; Lazzarino M
Ann Hematol; 2007 Aug; 86(8):619-22. PubMed ID: 17356849
[No Abstract] [Full Text] [Related]
57. [Richter's syndrome: analysis of literature data and original observations].
Osmanov DSh; Kruglova GV; Probatova NA; Kondrat'eva TT; Frenkel' MA; Sholokhova EN; Sorokin EN; Dvoretskiĭ VV; Tupitsyn NN
Ter Arkh; 1999; 71(7):47-58. PubMed ID: 10481868
[TBL] [Abstract][Full Text] [Related]
58. Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.
Dias JNR; André AS; Aguiar SI; Ministro J; Oliveira J; Peleteiro MC; Rütgen B; Gano L; Correia JDG; Oliveira SS; Goncalves J; Gil S; Tavares L; Aires-da-Silva F
PLoS One; 2018; 13(12):e0208147. PubMed ID: 30592723
[TBL] [Abstract][Full Text] [Related]
59. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
[TBL] [Abstract][Full Text] [Related]
60. Richter transformation: clonal identity does not indicate a linear disease progression.
Liu H; Yan Q; Nuako-Bandoh B; Grigoropoulos N; Huang Y; Follows G; Grant J; Lawton H; Wright P; Du MQ
Br J Haematol; 2012 Apr; 157(1):136-9. PubMed ID: 22050709
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
